Evidence map›Paper›PMID 40494919›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

Impact of white matter hyperintensities on α4β2 nicotinic acetylcholine receptor binding in the human brain.

Michael Rullmann, Philipp M Meyer, Andreas Schildan, Karl-Titus Hoffmann, Osama Sabri, Solveig Tiepolt

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michael RullmannDepartment of Nuclear Medicine, University of Leipzig, Liebigstr. 18, 04103, Leipzig, Germany. rullmann@medizin.uni-leipzig.de.ORCID 0000-0002-2683-9432
Philipp M MeyerDepartment of Nuclear Medicine, University of Leipzig, Liebigstr. 18, 04103, Leipzig, Germany.
Andreas SchildanDepartment of Nuclear Medicine, University of Leipzig, Liebigstr. 18, 04103, Leipzig, Germany.
Karl-Titus HoffmannDepartment of Neuroradiology, University of Leipzig Medical Center, Leipzig, Germany.
Osama Sabri *Department of Nuclear Medicine, University of Leipzig, Liebigstr. 18, 04103, Leipzig, Germany.
Solveig Tiepolt *Department of Nuclear Medicine, University of Leipzig, Liebigstr. 18, 04103, Leipzig, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWhite matter hyperintensities (WMHs) are commonly observed in aging and neurodegenerative diseases, but their impact on the α4β2 nicotinic acetylcholine receptor (α4β2-nAChR) system remains unclear. This study investigates the relationship between WMHs and gray matter nicotinic signaling, aiming to elucidate potential pathways contributing to neurodegeneration.

methodsMultimodal imaging data using PET and MR imaging from 39 participants, including 19 healthy controls and 20 patients with Alzheimer's disease dementia (AD), were analyzed. WMHs were identified on T1-weighted MPRAGE and T2-weighted TSE MR images using advanced segmentation algorithms. Probabilistic fiber tracking was applied to determine WMH-connected gray matter. PET-based total distribution volume (V

resultsWMH volumes were significantly correlated with age, Fazekas and MMSE scores, but no differences in absolute or relative WMH volumes were observed between healthy controls and patients with AD. PET-based V

conclusionThis study shows that WMHs do not significantly alter gray matter nicotinic signaling in directly connected regions. However, the results suggest subtle associations between WMH severity and specific cholinergic pathways, particularly in AD.

Indexed as

Receptors, NicotinicWhite MatterAgedAged, 80 and overAlzheimer DiseaseFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographyProtein Bindingnicotinic receptor alpha4beta2Receptors, Nicotinic(-)-[18F]FlubatineDTIFiber trackingMRIPETWhite matter hyperintensitiesα4β2 nicotinic acetylcholine receptor

Identifiers

PMID40494919
PMCPMC12589245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.